384 related articles for article (PubMed ID: 30406443)
1. Neuropharmacology of Synthetic Cathinones.
Baumann MH; Walters HM; Niello M; Sitte HH
Handb Exp Pharmacol; 2018; 252():113-142. PubMed ID: 30406443
[TBL] [Abstract][Full Text] [Related]
2. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical and Cardiovascular Effects of 4-Chloro Ring-Substituted Synthetic Cathinones in Rats.
Chojnacki MR; Thorndike EB; Partilla JS; Rice KC; Schindler CW; Baumann MH
J Pharmacol Exp Ther; 2023 Jun; 385(3):162-170. PubMed ID: 36669877
[TBL] [Abstract][Full Text] [Related]
4. Psychoactive "bath salts": not so soothing.
Baumann MH; Partilla JS; Lehner KR
Eur J Pharmacol; 2013 Jan; 698(1-3):1-5. PubMed ID: 23178799
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones.
Fitzgerald LR; Gannon BM; Walther D; Landavazo A; Hiranita T; Blough BE; Baumann MH; Fantegrossi WE
Neuropharmacology; 2024 Mar; 245():109827. PubMed ID: 38154512
[TBL] [Abstract][Full Text] [Related]
6. Neurotoxicology of Synthetic Cathinone Analogs.
Angoa-Pérez M; Anneken JH; Kuhn DM
Curr Top Behav Neurosci; 2017; 32():209-230. PubMed ID: 27753008
[TBL] [Abstract][Full Text] [Related]
7. Monoamine transporter and receptor interaction profiles of novel psychoactive substances: para-halogenated amphetamines and pyrovalerone cathinones.
Rickli A; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2015 Mar; 25(3):365-76. PubMed ID: 25624004
[TBL] [Abstract][Full Text] [Related]
8. Interactions of Cathinone NPS with Human Transporters and Receptors in Transfected Cells.
Simmler LD; Liechti ME
Curr Top Behav Neurosci; 2017; 32():49-72. PubMed ID: 27272068
[TBL] [Abstract][Full Text] [Related]
9. The synthetic cathinones, butylone and pentylone, are stimulants that act as dopamine transporter blockers but 5-HT transporter substrates.
Saha K; Li Y; Holy M; Lehner KR; Bukhari MO; Partilla JS; Sandtner W; Sitte HH; Baumann MH
Psychopharmacology (Berl); 2019 Mar; 236(3):953-962. PubMed ID: 30345459
[TBL] [Abstract][Full Text] [Related]
10. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological Actions of Synthetic Cathinones on Monoamine Transporters.
Solis E
Curr Top Behav Neurosci; 2017; 32():73-92. PubMed ID: 27677783
[TBL] [Abstract][Full Text] [Related]
12. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
[TBL] [Abstract][Full Text] [Related]
13. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
Kolaczynska KE; Thomann J; Hoener MC; Liechti ME
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361040
[TBL] [Abstract][Full Text] [Related]
14. DARK Classics in Chemical Neuroscience: Cathinone-Derived Psychostimulants.
Simmons SJ; Leyrer-Jackson JM; Oliver CF; Hicks C; Muschamp JW; Rawls SM; Olive MF
ACS Chem Neurosci; 2018 Oct; 9(10):2379-2394. PubMed ID: 29714473
[TBL] [Abstract][Full Text] [Related]
15. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs.
Baumann MH; Bukhari MO; Lehner KR; Anizan S; Rice KC; Concheiro M; Huestis MA
Curr Top Behav Neurosci; 2017; 32():93-117. PubMed ID: 27830575
[TBL] [Abstract][Full Text] [Related]
16. Deconstructed Analogues of Bupropion Reveal Structural Requirements for Transporter Inhibition versus Substrate-Induced Neurotransmitter Release.
Shalabi AR; Walther D; Baumann MH; Glennon RA
ACS Chem Neurosci; 2017 Jun; 8(6):1397-1403. PubMed ID: 28220701
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Cathinone Analogues Structurally Related to the Central Stimulant Methylphenidate as Dopamine Reuptake Inhibitors.
Yadav-Samudrala BJ; Eltit JM; Glennon RA
ACS Chem Neurosci; 2019 Sep; 10(9):4043-4050. PubMed ID: 31369229
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of designer cathinones in vitro.
Simmler LD; Buser TA; Donzelli M; Schramm Y; Dieu LH; Huwyler J; Chaboz S; Hoener MC; Liechti ME
Br J Pharmacol; 2013 Jan; 168(2):458-70. PubMed ID: 22897747
[TBL] [Abstract][Full Text] [Related]
19. The pharmacology and neurotoxicology of synthetic cathinones.
Angoa-Perez M; Kuhn DM
Adv Pharmacol; 2024; 99():61-82. PubMed ID: 38467489
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
